The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1003
June 20, 1997
View Complete Issue         Table of Contents 2019 
Topical Penciclovir for Herpes Labialis
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Topical Penciclovir for Herpes Labialis
June 20, 1997 (Issue: 1003)
Penciclovir 1% cream (Denavir - SmithKline Beecham) has been approved by the US Food and Drug Administration (FDA) for treatment of recurrent orolabial herpes simplex virus (HSV) infections in adults. Acyclovir (Zovirax) is also available in a...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Topical Penciclovir for Herpes Labialis
Article code: 1003a
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.